Ireland's only national dedicated respite centre for people living with multiple sclerosis may have to leave its beds lying idle for even longer because of a lack of funding.
A drug described as a landmark in treating multiple sclerosis is being reviewed for use in Europe. Trials suggest that Ocrelizumab can slow damage to the brain in two forms of MS, which offers a lot of hope for the future.
There were tears of joy in Rosaleen Rafter’s home when the Health Service Executive confirmed that it will repay the cost of a life-changing drug for people with multiple sclerosis.
Multiple Sclerosis (MS) Ireland says it is disappointed that an expert group failed to recommend a life-changing drug be made available through the HSE because it costs too much.
The availability of cannabis-based medicine to relieve one of the main symptoms of multiple sclerosis is about to move a step closer.
Epileptics have to wait for up to two years to see a specialist, an Oireachtas Committee heard today.
4 minutes ago
9 minutes ago
15 minutes ago
22 minutes ago
Sunday, September 20, 2020 - 3:00 PM
Sunday, September 20, 2020 - 9:00 AM
Sunday, September 20, 2020 - 8:00 AM